GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Ultralife Corp (NAS:ULBI) » Definitions » Cash, Cash Equivalents, Marketable Securities

ULBI (Ultralife) Cash, Cash Equivalents, Marketable Securities : $8.7 Mil (As of Mar. 2025)


View and export this data going back to 1992. Start your Free Trial

What is Ultralife Cash, Cash Equivalents, Marketable Securities?

Ultralife's quarterly cash, cash equivalents, marketable securities increased from Sep. 2024 ($6.77 Mil) to Dec. 2024 ($6.85 Mil) and increased from Dec. 2024 ($6.85 Mil) to Mar. 2025 ($8.72 Mil).

Ultralife's annual cash, cash equivalents, marketable securities increased from Dec. 2022 ($5.63 Mil) to Dec. 2023 ($10.20 Mil) but then declined from Dec. 2023 ($10.20 Mil) to Dec. 2024 ($6.85 Mil).


Ultralife Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Ultralife's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ultralife Cash, Cash Equivalents, Marketable Securities Chart

Ultralife Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.56 8.33 5.63 10.20 6.85

Ultralife Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.10 6.69 6.77 6.85 8.72

Ultralife Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Ultralife  (NAS:ULBI) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Ultralife Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Ultralife's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Ultralife Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Ultralife Corp (NAS:ULBI) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
Address
2000 Technology Parkway, Newark, NY, USA, 14513
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
Executives
Bradford T Whitmore 10 percent owner 5215 OLD ORCHARD ROAD, SUITE 620, SKOKIE IL 60077
W. Shaw Robert director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Thomas Louis Saeli director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Michael Edward Manna director, officer: President and CEO 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Janie Goddard director C/O ACON - 1133 CONNECTICUT AVENUE, NW, SUITE 700, WASHINGTON DC 20036
Philip A Fain officer: Vice President C/O CXO ON THE GO OF DELAWARE, LLC, 3349 MONROE AVENUE, # 256, ROCHESTER NY 14618
Michael D Popielec director, officer: President and CEO 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Steven Mark Anderson director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Sunray I, Llc 10 percent owner 1560 SHERMAN AVENUE, SUITE 900, EVANSTON IL 60201
James A. Croce director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Spurgeon Corp 10 percent owner 407 S. THIRD STREET, SUITE 230, GENEVA IL 60134
Patricia C Barron director 6601 WEST BROAD STREET, P O BOX 27003, RICHMOND VA 23261-7003
Daniel W Christman director C/O ENTEGRIS, INC., 129 CONCORD ROAD, BILLERICA MA 01821
Paula H Cholmondeley director 221 W PHILADELPHIA ST, SUITE 60W, YORK PA 17401-2991
Ranjit C Singh director